BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2483564)

  • 1. Calcium-entry blockers and arterial compliance in hypertension.
    Safar ME; Pannier B; Laurent S; London GM
    J Cardiovasc Pharmacol; 1989; 14 Suppl 10():S1-6; discussion S59-62. PubMed ID: 2483564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large arteries in hypertension: acute effects of a new calcium entry blocker, nitrendipine.
    Levenson J; Simon AC; Safar ME; Bouthier J; Maarek BC
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1006-10. PubMed ID: 6085357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Calcium inhibitors and arterial hypertension].
    Hugue C; Safar M
    J Mal Vasc; 1989; 14(4):356-9. PubMed ID: 2685164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal and vascular protective effects of cilnidipine in patients with essential hypertension.
    Morimoto S; Yano Y; Maki K; Iwasaka T
    J Hypertens; 2007 Oct; 25(10):2178-83. PubMed ID: 17885563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arterial compliance in hypertension.
    London GM; Marchais SJ; Safar ME
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():53-6. PubMed ID: 2674442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential responses of the heart and vasculature to chronic blood pressure reduction in essential hypertension.
    Lafleche A; Gautier S; Topouchian J; Wilmet CS; Girerd X; Safar ME; Benetos A
    Clin Pharmacol Ther; 1998 Jul; 64(1):96-105. PubMed ID: 9695724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaso-dilating drugs and the large arteries in essential hypertension.
    Safer ME; Levenson JA
    Artery; 1986; 14(1):1-27. PubMed ID: 2947552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radial artery compliance in essential hypertension: effects of antihypertensive therapy with lacidipine.
    Trazzi S; Santucciu C; Mancia G
    J Hypertens Suppl; 1993 Dec; 11(6):S17-20. PubMed ID: 8169377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of valsartan and nifedipine coat-core on systemic arterial stiffness in hypertensive patients.
    Munakata M; Nagasaki A; Nunokawa T; Sakuma T; Kato H; Yoshinaga K; Toyota T
    Am J Hypertens; 2004 Nov; 17(11 Pt 1):1050-5. PubMed ID: 15533733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of antihypertensive treatment on small artery remodeling in hypertension.
    Schiffrin EL
    Can J Physiol Pharmacol; 2003 Feb; 81(2):168-76. PubMed ID: 12710531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Representativeness of peripheral blood pressure values: the pulsatile component of blood pressure in hypertension.
    Safar M
    Z Kardiol; 1996; 85 Suppl 3():51-9. PubMed ID: 8896300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium-channel blockers for combined systemic hypertension and myocardial ischemia.
    Frishman WH; Charlap S
    Circulation; 1987 Jun; 75(6 Pt 2):V154-62. PubMed ID: 3552312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vessel wall properties of large arteries in hypertension and effect of antihypertensive treatment.
    Van Bortel LM; Kool MJ
    Can J Cardiol; 1994 Nov; 10 Suppl D():37D-40D. PubMed ID: 7954040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arterial pulse wave and calcium-channel blockers in hypertension.
    Pannier BM; London GM; Guerin AP; Benetos A; Safar ME
    J Cardiovasc Pharmacol; 1994; 23 Suppl 5():S67-70. PubMed ID: 7609511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Views on the use of calcium channel blockers in the treatment of heart ischemia and hypertension].
    Halawa B
    Pol Merkur Lekarski; 1998 Sep; 5(27):107-10. PubMed ID: 10101470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium, large arteries, and diuretic compounds in hypertension.
    Safar ME; Asmar R; Benetos A; Levy BI; London GM
    Am J Med Sci; 1994 Feb; 307 Suppl 1():S3-8. PubMed ID: 8141162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tissue selectivity of calcium channel blockers].
    Godfraind T
    C R Seances Soc Biol Fil; 1998; 192(1):121-35. PubMed ID: 9759358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potassium magnesium supplementation for four weeks improves small distal artery compliance and reduces blood pressure in patients with essential hypertension.
    Wu G; Tian H; Han K; Xi Y; Yao Y; Ma A
    Clin Exp Hypertens; 2006 Jul; 28(5):489-97. PubMed ID: 16820345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Differential therapy with calcium antagonists].
    Scholze JE
    Herz; 2003 Dec; 28(8):754-63. PubMed ID: 14689111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment for one year with perindopril: effect on cardiac mass and arterial compliance in essential hypertension.
    Asmar RG; Journo HJ; Lacolley PJ; Santoni JP; Billaud E; Levy BI; Safar ME
    J Hypertens Suppl; 1988 Dec; 6(3):S33-9. PubMed ID: 3225688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.